S&P 500   3,125.91 (-3.10%)
DOW   27,045.23 (-3.27%)
QQQ   215.28 (-2.76%)
AAPL   289.42 (-2.94%)
FB   197.36 (-1.68%)
MSFT   168.22 (-1.56%)
AMZN   1,967.02 (-2.10%)
CGC   19.61 (-3.45%)
BABA   205.06 (-0.53%)
MU   51.98 (-5.51%)
GE   11.20 (-5.56%)
TSLA   798.32 (-4.25%)
AMD   47.36 (-3.58%)
T   37.38 (-1.76%)
ACB   1.49 (-3.86%)
F   7.24 (-4.36%)
NFLX   360.06 (-2.34%)
BAC   31.08 (-5.04%)
DIS   128.29 (-3.55%)
GILD   69.23 (-5.03%)
S&P 500   3,125.91 (-3.10%)
DOW   27,045.23 (-3.27%)
QQQ   215.28 (-2.76%)
AAPL   289.42 (-2.94%)
FB   197.36 (-1.68%)
MSFT   168.22 (-1.56%)
AMZN   1,967.02 (-2.10%)
CGC   19.61 (-3.45%)
BABA   205.06 (-0.53%)
MU   51.98 (-5.51%)
GE   11.20 (-5.56%)
TSLA   798.32 (-4.25%)
AMD   47.36 (-3.58%)
T   37.38 (-1.76%)
ACB   1.49 (-3.86%)
F   7.24 (-4.36%)
NFLX   360.06 (-2.34%)
BAC   31.08 (-5.04%)
DIS   128.29 (-3.55%)
GILD   69.23 (-5.03%)
S&P 500   3,125.91 (-3.10%)
DOW   27,045.23 (-3.27%)
QQQ   215.28 (-2.76%)
AAPL   289.42 (-2.94%)
FB   197.36 (-1.68%)
MSFT   168.22 (-1.56%)
AMZN   1,967.02 (-2.10%)
CGC   19.61 (-3.45%)
BABA   205.06 (-0.53%)
MU   51.98 (-5.51%)
GE   11.20 (-5.56%)
TSLA   798.32 (-4.25%)
AMD   47.36 (-3.58%)
T   37.38 (-1.76%)
ACB   1.49 (-3.86%)
F   7.24 (-4.36%)
NFLX   360.06 (-2.34%)
BAC   31.08 (-5.04%)
DIS   128.29 (-3.55%)
GILD   69.23 (-5.03%)
S&P 500   3,125.91 (-3.10%)
DOW   27,045.23 (-3.27%)
QQQ   215.28 (-2.76%)
AAPL   289.42 (-2.94%)
FB   197.36 (-1.68%)
MSFT   168.22 (-1.56%)
AMZN   1,967.02 (-2.10%)
CGC   19.61 (-3.45%)
BABA   205.06 (-0.53%)
MU   51.98 (-5.51%)
GE   11.20 (-5.56%)
TSLA   798.32 (-4.25%)
AMD   47.36 (-3.58%)
T   37.38 (-1.76%)
ACB   1.49 (-3.86%)
F   7.24 (-4.36%)
NFLX   360.06 (-2.34%)
BAC   31.08 (-5.04%)
DIS   128.29 (-3.55%)
GILD   69.23 (-5.03%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 GlaxoSmithKlineSanofiAbbVieBristol-Myers SquibbAstraZeneca
SymbolNYSE:GSKNYSE:SNYNYSE:ABBVNYSE:BMYNYSE:AZN
Price Information
Current Price$41.45$49.06$88.44$61.66$46.73
52 Week RangeHoldBuyBuyBuyHold
Analyst Ratings
Consensus RecommendationHoldBuyBuyBuyHold
Consensus Price Target$49.00$55.33$89.30$62.64$50.68
% Upside from Price Target18.23% upside12.79% upside0.98% upside1.58% upside8.47% upside
Trade Information
Market Cap$104.60 billion$124.81 billion$140.43 billion$106.93 billion$131.63 billion
Beta0.710.670.960.760.48
Average Volume3,358,3741,583,8999,503,83713,659,8602,791,355
Sales & Book Value
Annual Revenue$43.10 billion$39.60 billion$33.27 billion$26.15 billion$24.38 billion
Price / Sales2.403.103.933.845.03
Cashflow$4.50 per share$5.39 per share$8.70 per share$5.29 per share$2.95 per share
Price / Cash9.229.1010.1711.6615.84
Book Value$9.40 per share$26.11 per share($5.61) per share$8.65 per share$5.56 per share
Price / Book4.411.88-15.767.138.40
Profitability
Net Income$5.93 billion$4.28 billion$7.88 billion$3.44 billion$1.34 billion
EPS$3.17$3.13$8.94$4.69$1.75
Trailing P/E Ratio17.4115.6716.7528.1688.16
Forward P/E Ratio13.3315.287.488.4717.90
P/E Growth$5.89$2.41$2.00$1.26$1.51
Net Margins13.72%12.20%23.69%13.15%5.38%
Return on Equity (ROE)57.93%18.18%-162.37%48.97%32.24%
Return on Assets (ROA)8.50%9.78%23.06%16.35%7.34%
Dividend
Annual Payout$2.37$1.16$4.72$1.80$0.88
Dividend Yield5.72%2.36%5.34%2.92%1.88%
Three-Year Dividend Growth-1.44%N/A22.62%4.89%-13.72%
Payout Ratio74.76%37.06%52.80%38.38%50.29%
Years of Consecutive Dividend Growth1 YearsN/A47 Years10 YearsN/A
Debt
Debt-to-Equity Ratio1.29%0.40%N/A1.37%1.11%
Current Ratio0.81%1.22%1.15%3.83%0.86%
Quick Ratio0.56%0.85%1.04%3.72%0.68%
Ownership Information
Institutional Ownership Percentage11.29%7.04%64.66%83.02%17.78%
Insider Ownership Percentage10.00%1.00%0.08%0.13%N/A
Miscellaneous
Employees95,490N/A30,00023,30064,400
Shares Outstanding2.50 billion2.50 billion1.48 billion1.63 billion2.62 billion
Next Earnings Date5/6/2020 (Estimated)4/24/2020 (Estimated)4/23/2020 (Estimated)4/23/2020 (Estimated)4/24/2020 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel